Purchase Order 75N98026P01202

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $19,428 on September 12, 2018, with an ultimate completion date of September 28, 2019. Work is performed at the awardee's location in Bethesda, Maryland. The order covers life science research instrumentation and related supplies on a firm fixed-price basis. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $8,544.00 on November 8, 2017, with ultimate completion November 7, 2018. Performance takes place in Bethesda, Maryland. The order covers life science research instrumentation and related supplies on a firm fixed-price basis. No set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,282.75 on September 7, 2017, with completion by October 8, 2017. No set-aside applied. Place of performance is Bethesda, Maryland. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,310.80 on August 28, 2017, with ultimate completion on July 16, 2018. The order is for life science research supplies and equipment sourced from Bio-Rad's Life Science Group Division. Place of performance is Bethesda, Maryland. No set-aside was used; the award carries firm fixed-price pricing on a full-and-open competitive basis.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. on August 16, 2016, with a ceiling value of $3,657.02 and an ultimate completion date of September 16, 2017. The order is firm fixed price with no set-aside. Work is performed in Bethesda, Maryland. Bio-Rad supplied laboratory equipment and instrumentation to support the Institute's research operations.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $4,729.00 on June 11, 2018, with an ultimate completion date of August 10, 2019. No set-aside was used. Performance takes place at Bethesda, Maryland. The order is for life science research equipment or supplies from Bio-Rad's Life Science Group Division on a firm fixed-price basis.</p>

<p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. for $7,500.00 on August 9, 2017, with ultimate completion by August 13, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for life science research equipment or related supplies and services from Bio-Rad's Life Science Group Division.</p>

The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc., Life Science Group Division, on September 5, 2018, with a ceiling value of $11,320.28 and an ultimate completion date of September 4, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is firm fixed price, covering life science research and clinical diagnostic equipment, reagents, or maintenance services characteristic of Bio-Rad's federal portfolio in analytical laboratory...

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $1,284.75 on November 13, 2015, with completion on November 14, 2016. No set-aside was used. Performance is located in Bethesda, Maryland. The order is firm fixed price. The specific equipment or reagent items procured are not detailed in the source.</p>

<p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. valued at $7,672.44 on August 9, 2016, with final completion scheduled for August 14, 2017. Work is performed at Bio-Rad's facility in Bethesda, Maryland. The order covers laboratory equipment, reagents, or consumables supplied on a firm fixed-price basis. No small business set-aside was applied.</p>